of women in the workforce, supplemented by efforts to extend parental leave, help the industry become a leader in reconciling work and family life.
years is the increase in life expectancy in Switzerland compared to 50 years ago. Innovative drugs have made a crucial contribution to this increase.
Our mission is to ensure that patients in Switzerland receive access to innovative medicines and therapies as quickly as possible.
The pharmaceutical industry in Switzerland will also need attractive framework conditions in future, including legal certainty, open export markets and the availability of labour.
show more articles
Interpharma, the association of Switzerland’s research-based pharmaceutical industry, was founded in Basel in 1933.
Interpharma informs the public about issues that are important to the research-based pharmaceutical industry in Switzerland, including the pharma market in Switzerland, healthcare and biomedical research.
Information on our key figures and activities in the financial year 2024
read more
Introducing Interpharma
read more
More about the tasks and overriding aims of Interpharma
read more
Contact us
read more
Latest information and media contacts for media representatives
read more
Download